The modification of the lone tryptophan residue in human serum albumin by 2-hydroxy-5-nitrobenzyl bromide. Characterization of the modified protein and the binding of L-tryptophan and benzodiazepines to the tryptophan-modified albumin.
The possible function of the lone tryptophan residue of human serum albumin in the stereospecific binding site for indole and benzodiazepine compounds was investigated by chemical modification. This residue can be selectively modified with 2-hydroxy-5-nitrobenzyl bromide. The modification alters the conformation of the albumin only slightly, as revealed by circular dichroism, fluorescence, and ultraviolet absorption measurements. A decrease in the association constants of L-tryptophan and diazepam of about 30 - 50% and a decrease in the extrinsic Cotton effects of four benzodiazepine derivatives of about 10 - 15% were found as specific effects of the tryptophan modification. The tryptophan modification itself did not change the number of binding sites of diazepam and L-tryptophan. It is suggested that the lone tryptophan residue of human serum albumin is not directly involved in the specific binding site for indole and benzodiazepine compounds. However, the modification alters the properties of the binding site either by an incomplete refolding of the albumin after urea treatment, or a more selective allosteric effect of the modified tryptophan residue.
D015077:2-Hydroxy-5-nitrobenzyl Bromide; D000495:Allosteric Site; D000596:Amino Acids / Q000032:analysis; D001569:Benzodiazepines; D002942:Circular Dichroism; D006801:Humans; D007700:Kinetics; D009596:Nitrophenols; D011485:Protein Binding; D011487:Protein Conformation; D012709:Serum Albumin; D013050:Spectrometry, Fluorescence; D013056:Spectrophotometry, Ultraviolet; D014364:Tryptophan
D000596:Amino Acids; D009596:Nitrophenols; D012709:Serum Albumin; D001569:Benzodiazepines; D015077:2-Hydroxy-5-nitrobenzyl Bromide; D014364:Tryptophan